We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Opening statements began on Tuesday in Oklahoma’s trial against Johnson & Johnson for the company’s alleged role in the opioid crisis—just two days after the state’s Attorney General Mike Hunter announced a settlement agreement with the other remaining defendant, Teva Pharmaceuticals, for $85 million.